myNEO

myNEO

Foundation date

01/12/2018

Sector

#Biotechnology / R&D Services

Subsector

• #Therapeutics - Cell therapy
• #Therapeutics - Peptides
• #R&D Services - Bioinformatics
• #R&D Services - CRO (Contract Research Organization)
• #R&D Services - Genomics

Therapeutic areas

• #Neoplasms / cancer / oncology

MyNEO is a Ghent-based biotech company that identifies, validates and explores therapeutic applications of personalized cancer vaccines starting from the patients tumor-specific mutations. The ImmunoEngine bioinformatic platform reports the personalized neoantigens of a patient sample, and is integrated within our end-to-end solution including state-of-the-art sequencing methods, in-vitro immunogenicity tests, and personalized mRNA vaccine construct production.